Energy And Related Services Tenders

Medicines with the Active Ingredient Ciclosporin (Atc: S01xa18)

Medicines with the Active Ingredient Tafluprost (Atc: S01ee05)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Formoterol Beclometasone (Exclusively Dafo. Ihp, Inh), Atc R03ak08 for the Period January 1St, 2024 - December 31St, 2025

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion as Part of the So-Called Open House Procedure.

Order Announcement - Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Filgrastim and the Trade Name Zarzio / Filgrastim Hexal

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion as Part of the So-Called Open House Procedure.

Conclusion not Excluding Drug Discount Agreement. in Accordance with Section 130A Paragraph 8 Sgb V Iwe Open House Model for the Active Ingredient Calcipotriol/Betamethasone (Atc Code who D05ax52), Limited to the Gel Administration

Contract Announcement - Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Filgrastim and the Trade Name Neupogen(R)

Invitation to Submit an Application for Participation in the Dynamic Procurement System for the Procurement of Services in the Technical Areas of Bitbw

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Dronedarone (Atc Code According to Who: C01bd07)